Tarrified
In a volatile month Milford funds fared well, and although some of our fund returns were negative, we...
Ryman Healthcare – is the worst now behind it?:
Ryman Healthcare has been in the news again after just...
Tomorrow’s tariff announcement by President Trump is widely anticipated around the globe. Milford Investment Analyst Jeremy Hutton talks to Ryan...
Ryman Healthcare has been in the news recently, raising $1bn of new equity – it’s second raise in two years....
Investing may be a long-game, but how do you stand firm when the ground is shaky? Milford Head of Wealth...
It’s reporting season for NZX-listed companies, with market expectations low after a tough second half of 2024. Milford Investment Analyst...
If you are over 50, do you know how much you need, whether you have enough and how long it...
It’s been a tough year for the domestic economy. As 2024 comes to a close, Milford Investment Analyst Jeremy Hutton...
APi Group is a global, market-leading industrial services provider headquartered in the US, and focused on non-discretionary, statutorily-mandated inspection, testing...
Santa likes election certainty
Milford funds continue to deliver strong returns, helped by the performance of underlying assets. Stock...
The OCR announcement is out. Milford Investment Analyst Katlyn Parker talks to Heather du Plessis-Allan about how the market reacted...
An ageing population means an increase in orthopedic surgeries. Milford Investment Analyst Dr Deb Lambie talks to Heather du Plessis-Allan...
